Sera Prognostics (SERA) EBITDA (2020 - 2026)
Sera Prognostics (SERA) posted EBITDA of -$9.4 million for Q1 2026, down 4.53% on a QoQ basis from -$9.0 million in Q4 2025, and down 1.19% year-over-year from -$9.5 million in Q1 2025.
Sera Prognostics (SERA) EBITDA (2020 - 2026) Analysis & Trends
Sera Prognostics' EBITDA history runs 7 years deep, the most recent figure standing at -$9.4 million for Q1 2026.
- Quarterly EBITDA fell 1.19% year-over-year to -$9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.6 million (changed 0.47% YoY) and the FY2025 annual result came in at -$36.5 million, changed 0.36% from the prior year.
- EBITDA was -$9.4 million for Q1 2026 at Sera Prognostics, down from -$9.0 million in the prior quarter.
- Across five years, EBITDA topped out at -$8.2 million in Q3 2023 and bottomed at -$12.3 million in Q1 2022.
- A 5-year average of -$9.9 million and a median of -$9.3 million in 2025 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA tumbled 104.15% — and 2023, when it gained 26.85%.
- Sera Prognostics' EBITDA stood at -$10.4 million in 2022, then increased by 15.07% to -$8.8 million in 2023, then decreased by 6.5% to -$9.4 million in 2024, then increased by 4.98% to -$9.0 million in 2025, then dropped by 4.53% to -$9.4 million in 2026.
- Business Quant data shows SERA's EBITDA at -$9.4 million in Q1 2026, -$9.0 million in Q4 2025, and -$9.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sera Prognostics | 109.06 Mn | 109.06 Mn | -28,000.00 | -9.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.36 Mn |
| Dec 31, 2025 | -8.95 Mn |
| Sep 30, 2025 | -8.98 Mn |
| Jun 30, 2025 | -9.32 Mn |
| Mar 31, 2025 | -9.25 Mn |
| Dec 31, 2024 | -9.42 Mn |
| Sep 30, 2024 | -8.86 Mn |
| Jun 30, 2024 | -9.25 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -8.85 Mn |
| Sep 30, 2023 | -8.18 Mn |
| Jun 30, 2023 | -11.46 Mn |
| Mar 31, 2023 | -11.33 Mn |
| Dec 31, 2022 | -10.42 Mn |
| Sep 30, 2022 | -11.19 Mn |
| Jun 30, 2022 | -11.75 Mn |
| Mar 31, 2022 | -12.30 Mn |
| Dec 31, 2021 | -12.55 Mn |
| Sep 30, 2021 | -9.44 Mn |
| Jun 30, 2021 | -7.38 Mn |